Organoids derived from ALS patient iPSCs can recapitulate key features of the disease, such as TDP-43 aggregation and neuronal hyperexcitability, providing valuable insights into ALS mechanisms and potential therapeutic targets (Tamaki et al., 2023). Here, TARDBP is linked to amyotrophic lateral sclerosis.